In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics.
Bone marrow suppression
Linezolid
Minimum inhibitory concentration
Multidrug resistance
Mycobacterium tuberculosis
Tedizolid
Journal
Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
29
01
2021
revised:
15
03
2022
accepted:
15
04
2022
pubmed:
22
5
2022
medline:
9
6
2022
entrez:
21
5
2022
Statut:
ppublish
Résumé
The effects of tedizolid (TZD) against multidrug-resistant Mycobacterium tuberculosis isolates were investigated. This is possibly the first study to evaluate the MIC of TZD against Japanese Mycobacterium tuberculosis isolates. As TZD had a significantly lower MIC than LZD (P < 0.01), it was suggested to be a better, non-toxic alternative to LZD.
Identifiants
pubmed: 35596983
pii: S0732-8893(22)00080-3
doi: 10.1016/j.diagmicrobio.2022.115714
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Oxazolidinones
0
Tetrazoles
0
tedizolid
97HLQ82NGL
Linezolid
ISQ9I6J12J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115714Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.